Prevalence and Burden of Vitiligo in Africa, the Middle East, and Latin America

The document reviews the prevalence and burden of vitiligo in Africa, the Middle East, and Latin America, highlighting significant variability in prevalence rates and a notable impact on quality of life (QoL). Vitiligo affects 0.5%-2.0% of the global population, with prevalence in these regions ranging from 0.18% to 5.3% in Africa and the Middle East, and 0.04% to 0.57% in Latin America. The review identifies a higher prevalence among females and common comorbidities such as autoimmune diseases and psychological issues. Despite the availability of QoL assessment tools, data remain limited, with stigma and psychosocial challenges being significant contributors to QoL impairment. The document emphasizes the need for comprehensive epidemiological studies, local management guidelines, and public awareness campaigns to address the psychosocial aspects and improve patient care.